Opportunity cost - stay OR go?, page-18

Yes, thanks for the thoughtful comment. I have a feeling that this is what IDT has been saying for a long time, and that message became important when they began saying it publicly in about August 2020. I have to say in the current context I’m surprised that their message of sovereign medicine manufacturing and local innovation hasn’t been rewarded with much work and therefore a raise in company value, but I don’t think this context is going away and in the mid term things will happen.

While it was disappointing the Moderna decision didn’t involve IDT, it does mean that Melbourne and Vic are now hotspots for this kind of work and others will be looking at that. IDT is in the right place at the right time doing the right thing, but as you say, just needs a short term catalyst or two to really get things moving!